Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Crown Records Management
Crown Records Management
Activities:
Patient Experience
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Healthcare professionals express opinions on personal data
Professionals in the healthcare sector want their personal data edited or deleted when GDPR comes in
Digital
Data management in the future
Pharma leads the way in long-term digital preservation as the battle hots up to keep data readable in future
Digital
Ten ways to shine a light on dark data in pharmaceuticals and find value in it
How businesses can benefit from finally taking control of the great unknown
Regulatory
Pharma sector praised for bringing data protection reforms despite Brexit
Half of companies see Brexit as an opportunity for Britain to position itself as the safest place to do business
Regulatory
Why pharmaceutical companies should still prepare for EU General Data Protection Regulation in the new year – regardless of Brexit
Don’t give up on data reforms just because UK is quitting Europe
Subscribe now